Home > Products > CD3 & PD1
> Recombinant Anti-CD3 x Anti-PD1 Bispecific Antibody (Minibody)
Recombinant Anti-CD3 x Anti-PD1 Bispecific Antibody (Minibody) (CAT#: MiniB-098)
Recombinant Anti-CD3 x Anti-PD1 Bispecific Antibody (Minibody) is designed to be expressed as the anti-CD3 scFv fused to N-terminus of Knob-CH3 domain and the anti-PD1 scFv to the Hole-CH3 domain, or vice versa. The CH3 domains are further stabilized by C-terminal disulfide bonds. This BsAb can retarget T cells to tumor cells. It is designed for the research of Esophageal cancer; Hodgkin lymphoma; Renal cell cancer (RCC); Mesothelioma; Head and neck squamous cell cancer (HNSCC); Anal cancer; Gastric cancer; Hepatocellular cancer; Nasopharyngeal cancer; Non-small cell lung cancer (NSCLC); Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-PD1 Bispecific Antibody (Minibody) (MiniB-098). Click the button below to contact us or submit your feedback about this product.